NFKB1 and colorectal cancer: Koosha et al. demonstrated that diosmetin inhibits cell proliferation and activates apoptosis signaling pathways in human colorectal cancer through the inhibition of the BMP (Bone morphogenetic proteins) and NF-κB pathways [57].